Anticoagulants in small cell lung cancer (SCLC): A randomized clinical trial comparing five weeks of heparin at curative dosage vs five months of low molecular weight heparin at preventive dosage

Cell Lung Cancer ◽

Small Cell ◽

Low Molecular Weight ◽

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer

Journal of Thrombosis and Haemostasis ◽

10.1111/j.1538-7836.2004.00871.x ◽

2004 ◽

Vol 2 (8) ◽

pp. 1266-1271 ◽

Cited By ~ 322

Author(s):

M. Altinbas ◽

H. S. Coskun ◽

O. Er ◽

M. Ozkan ◽

B. Eser ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Molecular Weight ◽

Small Cell Lung Cancer ◽

Combination Chemotherapy ◽

Small Cell ◽

Low Molecular Weight ◽

Regression of Metastatic Non-Small Cell Lung Cancer with Low Molecular Weight Heparin

Thrombosis and Haemostasis ◽

10.1055/s-0037-1613276 ◽

2002 ◽

Vol 88 (10) ◽

pp. 686-686 ◽

Cited By ~ 6

Author(s):

Leo Zacharski ◽

James Rigas ◽

James Loynes

Keyword(s):

Lung Cancer ◽

Molecular Weight ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Low Molecular Weight ◽

Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin

PLoS ONE ◽

10.1371/journal.pone.0207387 ◽

2018 ◽

Vol 13 (11) ◽

pp. e0207387 ◽

Cited By ~ 12

Author(s):

E. Gezelius ◽

A. Flou Kristensen ◽

P. O. Bendahl ◽

Y. Hisada ◽

S. Risom Kristensen ◽

...

Keyword(s):

Lung Cancer ◽

Molecular Weight ◽

Venous Thromboembolism ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Cell Lung Cancer ◽

Small Cell ◽

Low Molecular Weight ◽

Can Low-Molecular-Weight Heparin Improve the Outcome of Patients With Operable Non-Small Cell Lung Cancer?

CHEST Journal ◽

10.1378/chest.126.2.601 ◽

2004 ◽

Vol 126 (2) ◽

pp. 601-607 ◽

Cited By ~ 10

Author(s):

Marco Alifano ◽

Giovanni Benedetti ◽

Rocco Trisolini

Keyword(s):

Lung Cancer ◽

Molecular Weight ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Low Molecular Weight ◽

Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial

Annals of Oncology ◽

10.1093/annonc/mdx716 ◽

2018 ◽

Vol 29 (2) ◽

pp. 398-404 ◽

Cited By ~ 29

Author(s):

L. Ek ◽

E. Gezelius ◽

B. Bergman ◽

P.O. Bendahl ◽

H. Anderson ◽

...

Keyword(s):

Lung Cancer ◽

Molecular Weight ◽

Small Cell Lung Cancer ◽

Standard Treatment ◽

Small Cell ◽

Phase Iii ◽

Low Molecular Weight ◽

Small Cell Lung ◽

Phase Iii Trial

Predictive and Prognostic Potential of TP53 in Patients With Advanced Non–Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901)

Clinical Lung Cancer ◽

10.1016/j.cllc.2020.11.001 ◽

2020 ◽

Author(s):

Xiang-Meng Li ◽

Wen-Feng Li ◽

Jun-Tao Lin ◽

Hong-Hong Yan ◽

Hai-Yan Tu ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Egfr Tki

No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy: Results from a randomized clinical trial of 303 patients

Lung Cancer ◽

10.1016/0169-5002(93)90285-6 ◽

1993 ◽

Vol 10 (3-4) ◽

pp. 283

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7019 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7019-7019 ◽

Cited By ~ 14

Author(s):

G. M. Strauss ◽

J. Herndon ◽

M. A. Maddaus ◽

D. W. Johnstone ◽

E. A. Johnson ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Adjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Group B ◽

Leukemia Group

Phase II randomized clinical trial comparing immunotherapy plus stereotactic ablative radiotherapy (I-SABR) versus SABR alone for stage I, selected stage IIa or isolated lung parenchymal recurrent non-small cell lung cancer: I-SABR.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.tps8580 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS8580-TPS8580 ◽

Cited By ~ 4

Author(s):

Joe Y. Chang ◽

Lei Feng ◽

Steven H. Lin ◽

James William Welsh ◽

Mara Antonoff ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Stereotactic Ablative Radiotherapy ◽

Small Cell Lung ◽

Isolated Lung

Small cell lung cancer (SCLC) negative results of a randomized clinical trial on delayed thoracic radiotherapy administered to complete responders (CR) patients

Lung Cancer ◽

10.1016/0169-5002(91)91695-8 ◽

1991 ◽

Vol 7 ◽

pp. 94 ◽

Cited By ~ 1

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Negative Results